Bionano Genomics Inc (BNGO)
0.8606
+0.07
(+9.48%)
USD |
NASDAQ |
Apr 29, 16:00
0.8606
0.00 (0.00%)
After-Hours: 17:47
Bionano Genomics Enterprise Value: 16.05M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 26, 2024 | 16.05M |
April 25, 2024 | 14.39M |
April 24, 2024 | 14.52M |
April 23, 2024 | 16.56M |
April 22, 2024 | 14.49M |
April 19, 2024 | 13.84M |
April 18, 2024 | 16.12M |
April 17, 2024 | 17.87M |
April 16, 2024 | 20.30M |
April 15, 2024 | 21.19M |
April 12, 2024 | 27.77M |
April 11, 2024 | 30.98M |
April 10, 2024 | 31.59M |
April 09, 2024 | 32.21M |
April 08, 2024 | 32.82M |
April 05, 2024 | 23.70M |
April 04, 2024 | 21.87M |
April 03, 2024 | 23.70M |
April 02, 2024 | 22.47M |
April 01, 2024 | 26.44M |
March 28, 2024 | 28.63M |
March 27, 2024 | 27.53M |
March 26, 2024 | 24.80M |
March 25, 2024 | 24.25M |
March 22, 2024 | 24.80M |
Date | Value |
---|---|
March 21, 2024 | 25.89M |
March 20, 2024 | 25.34M |
March 19, 2024 | 24.80M |
March 18, 2024 | 23.70M |
March 15, 2024 | 23.16M |
March 14, 2024 | 23.70M |
March 13, 2024 | 26.98M |
March 12, 2024 | 25.89M |
March 11, 2024 | 28.63M |
March 08, 2024 | 30.27M |
March 07, 2024 | 30.81M |
March 06, 2024 | 34.09M |
March 05, 2024 | 33.00M |
March 04, 2024 | 34.09M |
March 01, 2024 | 36.28M |
February 29, 2024 | 36.28M |
February 28, 2024 | 26.02M |
February 27, 2024 | 27.39M |
February 26, 2024 | 21.44M |
February 23, 2024 | 20.07M |
February 22, 2024 | 20.99M |
February 21, 2024 | 21.44M |
February 20, 2024 | 23.27M |
February 16, 2024 | 25.10M |
February 15, 2024 | 26.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.04M
Minimum
Oct 27 2023
4.210B
Maximum
Feb 16 2021
430.80M
Average
115.07M
Median
Apr 28 2023
Enterprise Value Benchmarks
Bruker Corp | 11.98B |
Azenta Inc | 1.926B |
Harvard Bioscience Inc | 189.39M |
Akoya Biosciences Inc | 178.86M |
Singular Genomics Systems Inc | -135.16M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -43.89M |
Revenue (Quarterly) | 10.72M |
Total Expenses (Quarterly) | 35.67M |
EPS Diluted (Quarterly) | -0.96 |
Gross Profit Margin (Quarterly) | 22.74% |
Profit Margin (Quarterly) | -409.4% |
Earnings Yield | -2.07K% |
Normalized Earnings Yield | -1863.32 |